Metformin’s real power may be in the gut

For decades, physicians and scientists thought metformin, the leading type 2 diabetes medication taken by millions worldwide, mainly targets the liver to suppress glucose production. But a new Northwestern University study in mice has found this “wonder drug” instead focuses primarily on the gut, acting to prevent glucose levels rising in the blood by driving glucose utilization inside cells lining the intestine.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup